• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬体相关蛋白 1:卵巢癌治疗的潜在靶点。

The sequestosome 1 protein: therapeutic vulnerabilities in ovarian cancer.

机构信息

Fetomaternal Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Obstetrics and Gynecology Department, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Clin Transl Oncol. 2023 Oct;25(10):2783-2792. doi: 10.1007/s12094-023-03148-y. Epub 2023 Mar 25.

DOI:10.1007/s12094-023-03148-y
PMID:36964889
Abstract

Ovarian cancer (OC) is the most deadly tumor that may develop in a woman's reproductive system. It is also one of the most common causes of death among those who have been diagnosed with cancer in women. An adapter protein known as sequestosome 1(SQSTM1) or p62 is primarily responsible for the transportation, degradation, and destruction of a wide variety of proteins. This adapter protein works in conjunction with the autophagy process as well as the ubiquitin proteasome degradation pathway. In addition, the ability of SQSTM1 to interact with multiple binding partners link SQSTM1 to various pathways in the context of antioxidant defense system and inflammation. In this review, we outline the processes underlying the control that SQSTM1 has on these pathways and how their dysregulation contributes to the development of OC. At the final, the therapeutic approaches based on SQSTM1 targeting have been discussed.

摘要

卵巢癌(OC)是女性生殖系统中最致命的肿瘤之一。它也是女性癌症患者死亡的最常见原因之一。一种称为自噬相关蛋白 1(SQSTM1)或 p62 的衔接蛋白主要负责多种蛋白质的运输、降解和破坏。这种衔接蛋白与自噬过程以及泛素蛋白酶体降解途径协同作用。此外,SQSTM1 与多种结合伴侣相互作用的能力将 SQSTM1 与抗氧化防御系统和炎症中的各种途径联系起来。在这篇综述中,我们概述了 SQSTM1 对这些途径的控制过程,以及它们的失调如何导致 OC 的发展。最后,讨论了基于 SQSTM1 靶向的治疗方法。

相似文献

1
The sequestosome 1 protein: therapeutic vulnerabilities in ovarian cancer.自噬体相关蛋白 1:卵巢癌治疗的潜在靶点。
Clin Transl Oncol. 2023 Oct;25(10):2783-2792. doi: 10.1007/s12094-023-03148-y. Epub 2023 Mar 25.
2
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.一种依赖于SQSTM1/p62的可塑性自噬储备维持蛋白质稳态并决定多发性骨髓瘤细胞对蛋白酶体抑制剂的敏感性。
Autophagy. 2015;11(7):1161-78. doi: 10.1080/15548627.2015.1052928.
3
Cleavage of sequestosome 1/p62 by an enteroviral protease results in disrupted selective autophagy and impaired NFKB signaling.肠病毒蛋白酶切割自噬体相关蛋白 1/ p62 导致选择性自噬障碍和 NFKB 信号转导受损。
Autophagy. 2013 Oct;9(10):1591-603. doi: 10.4161/auto.26059. Epub 2013 Aug 13.
4
Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.自噬降解 SQSTM1 通过降低 DICER1 和 AGO2 诱导 MIRLET7A-3P,从而抑制卵巢癌细胞的迁移。
Autophagy. 2018;14(12):2065-2082. doi: 10.1080/15548627.2018.1501135. Epub 2018 Aug 17.
5
Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62.蛋白酶体和自噬体降解泛素化蛋白的动态变化:与自噬体相关蛋白 1/ p62 的关联。
J Biol Chem. 2011 Jun 24;286(25):22426-40. doi: 10.1074/jbc.M110.149252. Epub 2011 May 2.
6
New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.对骨 Paget 病发病机制中 sequestosome 1/p62 突变蛋白作用的新认识。
Endocr Rev. 2013 Aug;34(4):501-24. doi: 10.1210/er.2012-1034. Epub 2013 Apr 23.
7
The ICP0 Protein of Herpes Simplex Virus 1 (HSV-1) Downregulates Major Autophagy Adaptor Proteins Sequestosome 1 and Optineurin during the Early Stages of HSV-1 Infection.单纯疱疹病毒 1(HSV-1)的 ICP0 蛋白在 HSV-1 感染的早期阶段下调主要自噬衔接蛋白自噬体相关蛋白 1 和视神经萎缩症相关蛋白。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.01258-19. Print 2019 Nov 1.
8
PTX80, a novel compound targeting the autophagy receptor p62/SQSTM1 for treatment of cancer.PTX80,一种新型化合物,靶向自噬受体 p62/SQSTM1 用于癌症治疗。
Chem Biol Drug Des. 2022 Nov;100(5):623-638. doi: 10.1111/cbdd.14046. Epub 2022 Sep 4.
9
p62 at the interface of autophagy, oxidative stress signaling, and cancer.p62 在自噬、氧化应激信号和癌症的界面。
Antioxid Redox Signal. 2012 Sep 1;17(5):786-93. doi: 10.1089/ars.2011.4394. Epub 2012 Jan 11.
10
p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis.p62/SQSTM1/聚集体蛋白1是N端规则途径的一种N识别蛋白,可调节自噬体的生物发生。
Nat Commun. 2017 Jul 24;8(1):102. doi: 10.1038/s41467-017-00085-7.

引用本文的文献

1
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus.β-地中海贫血患者经西罗莫司治疗后,红系前体细胞中α-珠蛋白减少和自噬激活激酶 ULK1mRNA 增加。
Int J Mol Sci. 2023 Oct 10;24(20):15049. doi: 10.3390/ijms242015049.

本文引用的文献

1
SQSTM1/p62 regulate breast cancer progression and metastasis by inducing cell cycle arrest and regulating immune cell infiltration.SQSTM1/p62通过诱导细胞周期停滞和调节免疫细胞浸润来调控乳腺癌的进展和转移。
Genes Dis. 2021 Apr 20;9(5):1332-1344. doi: 10.1016/j.gendis.2021.03.008. eCollection 2022 Sep.
2
Wnt signaling in colorectal cancer: pathogenic role and therapeutic target.结直肠癌中的 Wnt 信号通路:致病作用和治疗靶点。
Mol Cancer. 2022 Jul 14;21(1):144. doi: 10.1186/s12943-022-01616-7.
3
PTX80, a novel compound targeting the autophagy receptor p62/SQSTM1 for treatment of cancer.
PTX80,一种新型化合物,靶向自噬受体 p62/SQSTM1 用于癌症治疗。
Chem Biol Drug Des. 2022 Nov;100(5):623-638. doi: 10.1111/cbdd.14046. Epub 2022 Sep 4.
4
Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation.同型半胱氨酸通过蛋白质半胱氨酸同型胱氨酸化抑制前胰岛素受体裂解并导致胰岛素抵抗。
Cell Rep. 2021 Oct 12;37(2):109821. doi: 10.1016/j.celrep.2021.109821.
5
Burden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017.1990-2017 年伊朗高血压性心脏病负担:2017 年全球疾病负担研究结果。
PLoS One. 2021 Sep 22;16(9):e0257617. doi: 10.1371/journal.pone.0257617. eCollection 2021.
6
Accelerate gas diffusion-weighted MRI for lung morphometry with deep learning.利用深度学习加速肺部形态测量的气体弥散加权 MRI。
Eur Radiol. 2022 Jan;32(1):702-713. doi: 10.1007/s00330-021-08126-y. Epub 2021 Jul 13.
7
Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction.通过自噬依赖性衰老诱导克服头颈部癌细胞的放射抵抗性:p62/SQSTM1 的表观遗传调控。
Cell Death Dis. 2021 Mar 5;12(3):250. doi: 10.1038/s41419-021-03539-5.
8
Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.卤夫酮调节成纤维细胞对 TGF-β诱导的瘢痕疙瘩纤维化反应。
Biomed Pharmacother. 2021 Mar;135:111182. doi: 10.1016/j.biopha.2020.111182. Epub 2021 Feb 1.
9
Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010-present).小分子 DNA-PK 抑制剂作为一种有潜力的癌症治疗方法:专利审查(2010 年至今)。
Expert Opin Ther Pat. 2021 May;31(5):435-452. doi: 10.1080/13543776.2021.1866540. Epub 2021 Feb 10.
10
Insight into the role of p62 in the cisplatin resistant mechanisms of ovarian cancer.深入了解p62在卵巢癌顺铂耐药机制中的作用。
Cancer Cell Int. 2020 Apr 16;20:128. doi: 10.1186/s12935-020-01196-w. eCollection 2020.